Alsop and colleagues [24] analyzed a series of 152 patients with peritoneal cancer and 40 with fallopian tube cancer and identified a total of 15.8% and 20% patients carrying a BRCA1/BRCA2 mutation, respectively. This evidence concerns the gene BRCA2 and peritoneum cancer.